• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients
 
  • Details
  • Full
Options
1994
Journal Article
Title

Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients

Abstract
Interstitial lung diseases often are accompanied by histopathologic evidence of alveolar type 2 cell alterations. In the alveolar milieu, the surfactant-specific protein A (SP-A) is a secretory product of alveolar type 2 cells. Therefore, we measured SP-A levels in bronchoalveolar lavage (BAL) fluids from patients with untreated sarcoidosis and hypersensitivity pneumonitis and compared the results with those from 21 healthy control subjects. In sarcoidosis patients, SP-A was markedly higher than in control subjects with a mean of 8.0 ug/ml of recovered BAL fluid +/-0.7 SEM. In HP, SP-A values were comparable with those in sarcoidosis with a mean of 9.0 ug/ml +/-1.7 SEM. Mean SP-A in the control group was 4.0 ug/ml +/-0.3 SEM. These results suggest that SP-A secretion is stimulated in sarcoidosis and HP. Further studies seem justified to investigate the role of the surfactant system in interstitial lung diseases as well as the potential clinical usefulness of SP-A measurements in BAL.
Author(s)
Hamm, H.
Lührs, J.
Guzman, J.
Costabel, U.
Fabel, H.
Bartsch, W.
Journal
Chest  
DOI
10.1378/chest.106.6.1766
Language
English
ITA  
Keyword(s)
  • allergy

  • bronchoalveolar lavage

  • hypersensitivity pneumonitis

  • lung

  • lung diseases

  • lymphoproliferative disorder

  • pneumonia

  • protein

  • pulmonary surfactant

  • respiratory system

  • sarcoidosis

  • surface active agent

  • tumor

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024